Debiotech and STMicroelectronics have introduced evaluation prototypes of a miniaturized insulin-delivery pump. The tiny device can be mounted on a disposable skin patch to provide continuous insulin infusion, enabling advancements in the availability, treatment efficiency and the quality of life of diabetes patients. The Nanopump, which relies on microfluidic MEMS (Micro-Electro-Mechanical System) technology, has successfully passed initial testing stages and is now ready to enter volume manufacturing.
The miniaturized disposable insulin pump combines Debiotech’s expertise in insulin delivery systems with ST’s strengths in manufacturing high-volume silicon-based microfluidic devices. The Nanopump is less than one fourth the size of existing insulin-pump devices and can be worn as a nearly invisible patch on the skin.
Debiotech, www.debiotech.com
STMicroelectronics, www.st.com
Caption
The insulin Nanopump, developed by Debiotech and industrialized by ST, represents the most advanced use of microfluidic MEMS technology in diabetes treatment.
